神经精神病症状与日常功能有关,正如认知不受损的老年人和他们的研究伙伴所报告的那样
Grace J Ma1, Mark A Dubbelman2,3, Catherine E Munro2,3
1Department of Psychiatry Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.
Alzheimer's & dementia (Amsterdam, Netherlands)
|February 25, 2026
概括
神经精神症状,如动机和情绪调节困难,与老年人日常功能减弱有关. 早期识别这些症状可能会提高生活质量和临床试验的敏感性.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 临床心理学 临床心理学
背景情况:
- 神经精神症状和功能衰退是阿尔茨海默病的早期指标.
- 这些早期迹象之间的相互作用往往被忽视.
- 这项研究调查了这些关系在认知不受损的老年人.
研究的目的:
- 检查神经精神症状与认知不受损的老年人日常功能之间的关联.
- 了解自我和研究伙伴报告的症状与功能能力的关系.
主要方法:
- 178名没有认知障碍的老年人 (平均年龄为70.4岁) 和他们的研究伙伴参与了这项研究.
- 参与者完成了轻度行为障碍检查清单 (MBI-C) 和日常生活预防仪器 (ADCS ADL-PI) 的阿尔茨海默病合作研究活动.
- 使用自我和研究合作伙伴报告数据分析了MBI-C和ADCSADL-PI得分之间的关联.
主要成果:
- 较高的MBI-C得分 (自我报告和研究合作伙伴报告) 与较低的ADCS ADL-PI得分有显著的关联.
- 这表明神经精神病症状增加与日常功能下降相关.
- 动机和情绪调节方面的困难成为关键预测因素.
结论:
- 神经精神病症状明显与认知不受损的老年人日常功能有关.
- 早期发现和管理这些症状可以改善生活质量.
- 解决这些症状也可能提高临床试验结果对早期认知衰退的敏感性.
相关概念视频
Cognitive Development During Adulthood
973
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
973
Negative and Cognitive Symptoms of Schizophrenia
758
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
758
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
720
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
720


